University of Thessaly (UTH)
Μελέτη μηχανισμών δράσης της υδροξυουρίας σε συνδυασμό με άλλες κυτταροκίνες σε καλλιέργειες αρχέγονων αιμοποιητικών κυττάρων
Abstract
dc:descriptionThe pathophysiological role of fetal hemoglobin in thalassemia was described in the beginning of the 1960s, when various genetical and biochemical studies attributed the survival of patients suffering severe abnormalities in chain to the existence of HbF. Thus, it was made clear that abundant production of fetal hemoglobin can considerably improve the clinical picture of patients suffering from -thalassemia and sickle cell anemia. Hence various pharmaceutical substances were tested - first on animals and subsequently on patients - which led to the increase in fetal hemoglobin. Research focused on the study of pharmaceutical substances which induced fetalhemoglobin in order to look into the mechanisms of action (MOA) of the subjects. According to hitherto findings, the mechanisms of action (MOA) of various inductive to HbF substances are diverse and usually involve action in cell proliferation and cellular differentiation or directly in the transcription of globin gene, increasing the levels of ymRNA transcripts, as well as interaction between intercellular signals. On one hand, there is great interest in the study of the y globin gene molecular regulation mechanism and, on the other hand, in finding new pharmacology-relatedfactors that increase the production of HbF. The substances which increase HbF ensure the promotion of BFU-EF cells, which preserve the y globin chain production program, and the absence of normal BFU-E, at the same time. Bibliographical references pertaining to the participation of post-transcription and translation mechanisms in the expression of globin genes and the action of inductive to HbF substances are limited. The aim of this study is to focus on the hydroxyurea mechanism of action to induce fetal hemoglobin, used either alone or in combination with cytokines, erythropoietin and SCF in a transcription, post-transcription and translation level. The primary CD34+ cell cultures of adult peripheral blood compose the study system which allows cellular differentiation towards erythroid lineage and excels all other culture systems so that the mechanism of action of HU and of its combination with Epo and SCF is studied. We observed the stages of the culture and the modification in the surface markers CD34, CD71, CD117 and glycophorin A (GPA), as well as the production of cells which compose HbF. The culture lasts 14 days. In this time-span, CD34 cells differentiate in mature erythroid cells expressing high levels of CD71 and glycophorin, low levels of CD117 and moderate levels of HbF. The increase in the concentration of erythropoietin (from 4 to 10 u/ml) affects cellular differentiation and leads to the increase in the expression ratio of GPA+, GPA+/HbF and F+ cells. The increase in GPA+cells and in the intracellular levels of expression of CD71 indicates faster development of the cells, rendering them possible to end updifferentiated. When the inductive factor (hydroxyurea-HU) is used in cultures, the number of cellswhich express HbF increases and remains higher than the number of control cells, even on the 14th day of the culture. However, the action of high concentration of Epo and HU in combination does not ensure any further increase in F+ cells numbers. SCF administration is important in the former stages of development of the culture of control cell for the proliferation and differentiation of the cells as well as for the production of HbF. As the differentiation of the cells is proceeding and the globin switching takes place, the number of F+ cells decreases. Nevertheless, we noticed thatretaining SCF in cells which conduct normal erythropoiesis (control cells) after the stage of proerythroblast results in the increase in the number of cells and in the decreased production of HbF, in comparison to the cells where the administration of SCF was ceased. On the contrary, retaining it in cells which conduct erythropoiesis under stress (they receive HU) results in a higher number of F+ cells, in comparison to the cells where the administration of SCF was ceased. It is thus proven that the path activated by the combination of SCF with the receptor of CD117 acts in cells that undergo stress erythropoiesis in an advanced stage of development, as it also occurs by using HU. Therefore, it is shown that SCF synergizes with HU in increasing F-cells. The co-existence of the factors mentioned above enhances cell proliferation, directly resulting in the reduction of their nutrient stores, which consequently leads to a delay of differentiation. The hemoglobin produced is measured with High Pressure Liquid Chromatography (HPLC) for chain analysis. After HU action and by retaining SCF after the stage of proerythroblast, we notice that the ratio Gy/Αγ increases, which triggers Gy globin chain; yet, the amount of the produced HbF is reduced until the 11th day of the culture, compared to the control cells, and increases on the 14th day. Finally, in cultures of mature erythroblasts with HU action, the number of F-cells increases and HbF is produced triggering Gy globin chain, if the administration of SCF continues. The increased production of HbF hemoglobin is noted on the 14th day of the culture. On the contrary, in cultures where SCF administration is ceased and HU is administrated after the stage of proerythroblast, cell differentiation is proceeding much faster. On the 12th day the cell increases HbF production levels to the ones it was before, because of HU action, but also triggers Gy globin chain, and on the 14th day the productiondecreases to the production levels of the control cells. Studying γ-mRNA transcripts, at the same time, we also observed that their production in the control cells increases from the 6th to the 8th day of culture, whereas on the 12th day their production decreases as their maturation has proceeded and the synthesis of βtranscripts has increased. The cells receiving ΙΟΟμΜ HU for one day, either continuously or pulse treatment increase the production levels of -mRNA transcripts on the 12th day of the culture. The production of HbF, as expressed by (γ/β+γ) transcripts ratio, increases with the action of ΙΟΟμΜ HU, by continuous or pulse treatment for one day, and is higher on the 8th day. Conversely, HU administration does not affect HbA (β/β+γ) whatsoever. Furthermore, we noticed that SCF action in mature erythroblasts and increase of the administrated Epo (from 4 to lOu/ml) results in modifications in β- and -mRNA transcripts. SCF administration increases the production ofY-mRNA transcripts. On the 6th day, this increase is small in the cells receiving HU, yet on the 12th day the production of -mRNA transcripts significantly increases in control cell with the action of both Epo concentrations (4 and ΙΟμΜ), as much as with HU action.It is clear that SCF and Epo are complementary to HU to produce -mRNA transcripts. Apart from the action in post-transcription level, the action of HU in the maturation of γmRNA transcripts was also remarked, since the interaction of HU with a transcription inhibitor, actinomycin D, contributes to the increase of -mRNA transcripts. Moreover, we did not witness action of any translation mechanism, since γ-mRNA transcripts induced by HU was not affected when the translation switched off by using cycloheximide. Further increase in the levels of -mRNA transcripts, by using HU and simultaneously adding CX as well as act-D, may be attributed to hydroxyurea action in the level of transcription and post-transcription maturation, as indicated by its action when thetranscription switches off for 24 hours, where the binding action of HU appears intense in -mRNA transcripts. The outcomes of this study provided crucial information about the mechanisms involvedin the action of hydroxyurea in globin genes, both with and without the presence of other cytokines, and significant data in order to study their interaction, too.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Likousi, Sophia
- Λυκούση, Σοφία
Subjects
dc:subject × 8Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/33871